By limiting joint damage, disability is reduced. The primary treatment for rheumatoid arthritis is medication to reduce immune system activity and inflammation. Five categories of drugs commonly used ...

There is a bidirectional association between rheumatoid arthritis (RA ... muscle and bone diseases. Various treatments are available. Non-pharmacological treatment includes physical therapy ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA ... concomitant medications and illnesses, dates of studies performed ...

Study to determine which treatments best for which inflammatory arthritis patients should result in patients being better ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.

MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Rheumatoid Arthritis.

Consult with your healthcare provider to possibly modify your treatment plan, including your RA medication, to both minimize the effects of a flare and help prevent future ones. Bykerk VP, Bingham CO, ...

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.